Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice

Blood. 2016 Dec 15;128(24):2859-2862. doi: 10.1182/blood-2016-07-729871. Epub 2016 Oct 31.

Tayebeh Soheili^{1

2

3}, Julie Rivière^{1

2}, Ida Ricciardelli⁴, Amandine Durand^{1

2}, Els Verhoeyen^{5

6}, Anne-Céline Derrien^{1

2}, Chantal Lagresle-Peyrou^{1

2

3}, Geneviève de Saint Basile^{2

7

8}, François-Loïc Cosset⁵, Persis Amrolia⁴, Isabelle André-Schmutz^{1

2}, Marina Cavazzana^{1

2

3}

¹ Human Lymphohaematopoiesis Laboratory, INSERM U1163, Paris, France.
² IMAGINE Institute, University of Paris Descartes-Sorbonne Paris Cité, Paris, France.
³ Biotherapy Clinical Investigation Centre, Necker Children's Hospital, Paris, France.
⁴ Molecular and Cellular Immunology Unit, Institute of Child Health, London, United Kingdom.
⁵ Centre International de Recherche en Infectiologie, Enveloped Viruses, Vectors and Innate Responses Research Group, Lyon University, Lyon, France.
⁶ C3M, Équipe Contrôle Métabolique des Morts Cellulaires, INSERM U1065, Nice, France.
⁷ Normal and Pathological Homeostasis of the Immune System Laboratory, INSERM U1163, Paris, France; and.
⁸ Centre d'Etudes des Déficits Immunitaires, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France.

No abstract available

Publication types